Toss Up for Second-Line IBD Tx; Screening for Esophageal Cancer; 100 Colon Polyps

(MedPage Today) -- Effectiveness of vedolizumab (Entyvio) and tofacitinib (Xeljanz) for ulcerative colitis or vedolizumab and ustekinumab (Stelara) for Crohn's disease did not significantly differ among patients who failed on tumor necrosis factor...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news